 |
|
|
| |
Keeping the Pressure on Archived NRTI Resistance: Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Triple Therapy in Study 4030
|
| |
| |
Reported by Jules Levin
Mexico City IAS 2019 July 21-24
Rima Acosta, Madeleine Willkom, Kristen Andreatta, Hui Liu, Ross Martin, Aiyappa Parvangada, Hal Martin, Sean Collins, and Kirsten L. White Gilead Sciences, Inc., Foster City, CA, USA
|
| |
|
|
|
|
|
